Search Results - "King, Shelby M"

Refine Results
  1. 1

    The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease by Mori, Akihisa, Chen, Jiang-Fan, Uchida, Shinichi, Durlach, Cecile, King, Shelby M., Jenner, Peter

    Published in Molecules (Basel, Switzerland) (06-04-2022)
    “…The adenosine A2A receptor subtype is recognized as a non-dopaminergic pharmacological target for the treatment of neurodegenerative disorders, notably…”
    Get full text
    Journal Article
  2. 2

    The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer by King, Shelby M, Hilliard, Tyvette S, Wu, Lucia Y, Jaffe, Randal C, Fazleabas, Asgerally T, Burdette, Joanna E

    Published in Endocrine-related cancer (01-10-2011)
    “…Ovarian cancer is the most lethal gynecological malignancy affecting American women. Current hypotheses concerning the etiology of ovarian cancer propose that…”
    Get full text
    Journal Article
  3. 3

    Istradefylline effects on tremor dominance (TD) and postural instability and gait difficulty (PIGD) by Torres-Yaghi, Yasar, Hattori, Nobutaka, Rascol, Olivier, Nakajima, Yu, King, Shelby M., Mori, Akihisa, Pagan, Fernando

    “…In patients with Parkinson’s Disease (PD), two distinct motor subtypes, tremor dominant (TD) and postural instability and gait difficulty (PIGD), can be…”
    Get full text
    Journal Article
  4. 4

    A new sperm-specific Na + /H + Exchanger required for sperm motility and fertility by Garbers, David L, Wang, Dan, King, Shelby M, Quill, Timothy A, Doolittle, Lynda K

    Published in Nature cell biology (01-12-2003)
    “…It has long been speculated that intracellular pH is a critical regulator of both invertebrate and vertebrate sperm motility, and sodium-hydrogen exchange has…”
    Get full text
    Journal Article
  5. 5

    Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer by Ó hAinmhire, Eoghainín, Quartuccio, Suzanne M, Cheng, Whay, Ahmed, Roshan A, King, Shelby M, Burdette, Joanna E

    Published in PloS one (20-02-2014)
    “…Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome Atlas Network identified p53 mutations in 96% of…”
    Get full text
    Journal Article
  6. 6

    Phosphatidylinositol 3,4,5-trisphosphate localization in recycling endosomes is necessary for AP-1B-dependent sorting in polarized epithelial cells by Fields, Ian C, King, Shelby M, Shteyn, Elina, Kang, Richard S, Fölsch, Heike

    Published in Molecular biology of the cell (01-01-2010)
    “…Polarized epithelial cells coexpress two almost identical AP-1 clathrin adaptor complexes: the ubiquitously expressed AP-1A and the epithelial cell-specific…”
    Get full text
    Journal Article
  7. 7

    Evaluating the progenitor cells of ovarian cancer: analysis of current animal models by King, Shelby M., University of Illinois at Chicago, Chicago, IL, USA, Burdette, Joanna E., University of Illinois at Chicago, Chicago, IL, USA

    Published in BMB reports (01-07-2011)
    “…Serous ovarian cancer is one of the most lethal gynecological malignancies. Progress on effective diagnostics and therapeutics for this disease are hampered by…”
    Get full text
    Journal Article
  8. 8
  9. 9

    3D Proximal Tubule Tissues Recapitulate Key Aspects of Renal Physiology to Enable Nephrotoxicity Testing by King, Shelby M, Higgins, J William, Nino, Celina R, Smith, Timothy R, Paffenroth, Elizabeth H, Fairbairn, Casey E, Docuyanan, Abigail, Shah, Vishal D, Chen, Alice E, Presnell, Sharon C, Nguyen, Deborah G

    Published in Frontiers in physiology (08-03-2017)
    “…Due to its exposure to high concentrations of xenobiotics, the kidney proximal tubule is a primary site of nephrotoxicity and resulting attrition in the drug…”
    Get full text
    Journal Article
  10. 10

    Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction by King, Shelby M, Quartuccio, Suzanne M, Vanderhyden, Barbara C, Burdette, Joanna E

    Published in Carcinogenesis (New York) (01-05-2013)
    “…Ovarian cancer is the deadliest gynecological malignancy due to detection of cancer at a late stage when the disease has metastasized. One likely progenitor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Evaluating the progenitor cells of ovarian cancer: analysis of current animal models by King, Shelby M, Burdette, Joanna E

    Published in BMB reports (30-07-2011)
    “…Serous ovarian cancer is one of the most lethal gynecological malignancies. Progress on effective diagnostics and therapeutics for this disease are hampered by…”
    Get full text
    Journal Article
  13. 13

    Abstract 2034: Development of 3D bioprinted human breast cancer for in vitro drug screening by King, Shelby M., Presnell, Sharon C., Nguyen, Deborah G.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract As breast cancer is a disease of multiple cell types in which the growth, invasion, and metastasis of epithelial carcinomas is heavily influenced by…”
    Get full text
    Journal Article
  14. 14

    Alginate hydrogels for three-dimensional organ culture of ovaries and oviducts by King, Shelby M, Quartuccio, Suzanne, Hilliard, Tyvette S, Inoue, Kari, Burdette, Joanna E

    Published in Journal of visualized experiments (20-06-2011)
    “…Ovarian cancer is the fifth leading cause of cancer deaths in women and has a 63% mortality rate in the United States(1). The cell type of origin for ovarian…”
    Get full text
    Journal Article
  15. 15

    Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway by King, Shelby M, Modi, Dimple A, Eddie, Sharon L, Burdette, Joanna E

    Published in Journal of ovarian research (07-02-2013)
    “…The ovarian surface epithelium responds to cytokines and hormonal cues to initiate proliferation and migration following ovulation. Although insulin and IGF…”
    Get full text
    Journal Article
  16. 16

    The Pharmacological Potential of Adenosine A 2A Receptor Antagonists for Treating Parkinson's Disease by Mori, Akihisa, Chen, Jiang-Fan, Uchida, Shinichi, Durlach, Cecile, King, Shelby M, Jenner, Peter

    Published in Molecules (Basel, Switzerland) (06-04-2022)
    “…The adenosine A receptor subtype is recognized as a non-dopaminergic pharmacological target for the treatment of neurodegenerative disorders, notably…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mutation or Loss of p53 Differentially Modifies TGF[beta] Action in Ovarian Cancer by Ó hAinmhire, Eoghainín, Quartuccio, Suzanne M, Cheng, Whay, Ahmed, Roshan A, King, Shelby M, Burdette, Joanna E

    Published in PloS one (20-02-2014)
    “…Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome Atlas Network identified p53 mutations in 96% of…”
    Get full text
    Journal Article
  19. 19
  20. 20